Prev. Article Next Article Table of Contents

Article

The SMN Interactome Includes Myb-Binding Protein 1a

Figures
Citing Articles

Your current credentials do not allow retrieval of the full text.

Purchase the full-text

PDF/HTML,
figures/images,
references and tables,
(where available)

Heidi R. Fuller^†^‡, Nguyen Thi Man^†, Le Thanh Lam^†, Le Thiet Thanh^§, Rebecca A. Keough, Arndt Asperger, Thomas J. Gonda^# and Glenn E. Morris*^†^‡

Wolfson Centre for Inherited Neuromuscular Disease, RJAH Orthopaedic Hospital, Oswestry, SY10 7AG, United Kingdom, Institute for Science and Technology in Medicine, Keele University, Staffordshire, United Kingdom, School of Biomedical Sciences, The Ohio State University, Columbus, Ohio 43210, School of Molecular and Biomedical Science, University of Adelaide, Adelaide, SA 5005, Australia, Bruker Daltonik GmbH, Bremen, Germany, and Diamantina Institute for Cancer, Immunology and Metabolic Medicine, University of Queensland, Brisbane, QLD 4102, Australia

J. Proteome Res., 2010, 9 (1), pp 556–563

DOI: 10.1021/pr900884g

Publication Date (Web): November 23, 2009

* To whom correspondence should be addressed. E-mail: Glenn.morris@rjah.nhs.uk. Telephone: 44-1691-404155. Fax: 44-1691-404170., †

RJAH Orthopaedic Hospital.

, ‡

Keele University.

, §

The Ohio State University.

University of Adelaide.

Bruker Daltonik GmbH.

, #

University of Queensland.

Section:

Mammalian Biochemistry

Abstract

Understanding networks of interacting proteins is a major goal in cell biology. The survival of motor neurons protein (SMN) interacts, directly or indirectly, with a large number of other proteins and reduced levels of SMN cause the inherited disorder spinal muscular atrophy (SMA). Some SMN interactions are stable and stoichiometric, such as those with gemins, while others are expected to be transient and substoichiometric, such as the functional interaction of SMN with coilin in Cajal bodies. This study set out to determine whether novel components of the extensive SMN interactome can be identified by a proteomic approach. SMN complexes were immuno-precipitated from HeLa nuclear extracts, using anti-SMN monoclonal antibody attached to magnetic beads, digested with trypsin, separated by capillary-liquid chromatography and analyzed by MALDI TOF/TOF mass spectrometry. One-hundred and one proteins were detected with a p value of <0.05, SMN, gemins and U snRNPs being the dominant “hits”. Sixty-nine of these were rejected after MALDI analysis of two control pull-downs using antibodies against unrelated nuclear proteins. The proteins found only in anti-SMN pulldowns were either known SMN partners, and/or contained dimethylated RG domains involved in direct interaction with the SMN tudor domain, or they were known binding partners of such direct SMN interactors. Myb-binding protein 1a, identified as a novel candidate, is a mainly nucleolar protein of unknown function but it partially colocalized with SMN in Cajal bodies in HeLa cell nucleoplasm and, like SMN, was reduced in cells from an SMA patient.

Keywords:

SMN; Myb-binding protein 1a; Cajal body; nucleolus; MALDI TOF/TOF; mass spectrometry; immunoprecipitation; interaction; SMA

View: Full Text HTML | Hi-Res PDF | PDF w/ Links

Citing Articles

View all 1 citing articles

Citation data is made available by participants in CrossRef's Cited-by Linking service. For a more comprehensive list of citations to this article, users are encouraged to perform a search in SciFinder.

This article has been cited by 1 ACS Journal articles (1 most recent appear below).

Valproate and Bone Loss: iTRAQ Proteomics Show that Valproate Reduces Collagens and Osteonectin in SMA Cells
Heidi R. Fuller, Nguyen Thi Man, Le Thanh Lam, Vladimir A. Shamanin, Elliot J. Androphy and Glenn E. Morris
Journal of Proteome Research2010 9 (8), 4228-4233
- Valproate and Bone Loss: iTRAQ Proteomics Show that Valproate Reduces Collagens and Osteonectin in SMA Cells
  Heidi R. Fuller, Nguyen Thi Man, Le Thanh Lam, Vladimir A. Shamanin, Elliot J. Androphy and Glenn E. Morris
  Journal of Proteome Research2010 9 (8), 4228-4233
  Valproate is commonly used as an anticonvulsant and mood stabilizer, but its long-term side-effects can include bone loss. As a histone deacetylase (HDAC) inhibitor, valproate has also been considered for treatment of spinal muscular atrophy (SMA). Using ...
  Abstract | Full Text HTML | Hi-Res PDF | PDF w/ Links